Form 8-K - Current report:
SEC Accession No. 0001437749-21-029110
Filing Date
2021-12-22
Accepted
2021-12-22 16:30:36
Documents
14
Period of Report
2021-12-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tech20211222_8k.htm   iXBRL 8-K 34505
2 EXHIBIT 99.1 ex_318904.htm EX-99.1 4147
  Complete submission text file 0001437749-21-029110.txt   173506

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tech-20211220.xsd EX-101.SCH 3594
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tech-20211220_def.xml EX-101.DEF 11425
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tech-20211220_lab.xml EX-101.LAB 15311
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tech-20211220_pre.xml EX-101.PRE 11585
8 EXTRACTED XBRL INSTANCE DOCUMENT tech20211222_8k_htm.xml XML 2552
Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address 614 MCKINLEY PL N E MINNEAPOLIS MN 55413 6123798854
BIO-TECHNE Corp (Filer) CIK: 0000842023 (see all company filings)

EIN.: 411427402 | State of Incorp.: MN | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-17272 | Film No.: 211513661
SIC: 2836 Biological Products, (No Diagnostic Substances)